Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16644581 | 1.00 | ABL1 (1.00) | ABL1BCR | |
| SCHEMBL30788435 | 0.94 | ABL1 (0.88) | ABL1 | |
| SCHEMBL30788443 | 0.94 | ABL1 (0.88) | ABL1 | |
| SCHEMBL30788449 | 0.93 | ABL1 (0.87) | ABL1BCR | |
| SCHEMBL15442784 | 0.93 | ABL1 (0.87) | ABL1BCR | |
| SCHEMBL24123159 | 0.92 | ABL1 (1.00) | ABL1BCR | |
| SCHEMBL30011770 | 0.92 | ABL1 (1.00) | ABL1 | |
| SCHEMBL24123283 | 0.92 | ABL1 (1.00) | ABL1BCR | |
| SCHEMBL30011137 | 0.92 | ABL1 (1.00) | ABL1BCR | |
| SCHEMBL30010951 | 0.92 | ABL1 (1.00) | ABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4580617-A2 | SMALL MOLECULE INHIBITORS OF BCR-ABL | Oregon Health & Science University (US) | 2025-07-09 | — | — | EP | disclosed |
| CN-120018845-A | Small molecule inhibitors of BCR-ABL | 俄勒冈健康与科学大学 | 2025-05-16 | — | — | CN | disclosed |
| WO-2024049854-A2 | SMALL MOLECULE INHIBITORS OF BCR-ABL | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2024-03-07 | — | — | WO | disclosed |
| EP-4326269-A1 | COMPOUNDS WITH IMPROVED CARDIAC SAFETY FOR THE TREATMENT OF CANCER AND NEURODEGENERATIVE DISORDERS | Oregon Health & Science University (US) | 2024-02-28 | — | — | EP | disclosed |
| WO-2022225972-A1 | COMPOUNDS WITH IMPROVED CARDIAC SAFETY FOR THE TREATMENT OF CANCER AND NEURODEGENERATIVE DISORDERS | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2022-10-27 | — | — | WO | disclosed |